Research Studies
LUMA Study (Biogen)
Criteria
About this study
The goal of this study is to investigate whether BIIB122 (study drug) may delay progression of PD. You may be eligible to participate if you are between 30 to 80 years of age and have been recently diagnosed with early-stage PD.